Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Global Pharmatech Inc
GBLPCurrent price
0.15 USD
0 USD (0.00%)
Last closed
0.15 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
PINK
Capitalization
60 269 832 USD
Yield for 12 month
-36.46 %
1Y
3Y
5Y
10Y
15Y
GBLP
Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China. Address: 509 Maoxiang Street, Changchun, China, 130 012
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+66 375 USD
Last Year
+58 585 USD
Current Quarter
+113 456 USD
Last Quarter
+26 850 USD
Current Year
+43 820 USD
Last Year
+29 397 USD
Current Quarter
+5 205 USD
Last Quarter
+15 099 USD
Key Figures GBLP
1 year
3 years
5 years
10 years
EBITDA
-1 813 375 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-10.39 %
PEG Ratio
–
Return On Equity TTM
-22.59 %
Wall Street Target Price
–
Revenue TTM
3 179 509 USD
Book Value
0.34 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
21.50 %
Dividend Yield
–
Gross Profit TTM
1 316 249 USD
Earnings per share
-0.23 USD
Diluted Eps TTM
-0.23 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-70.45 %
Dividend Analytics GBLP
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History GBLP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
03.02.2005
Dividend Date
–
Stock Valuation GBLP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
18.96
Enterprise Value EBITDA
0.058
Price Book MRQ
0.18
Financials GBLP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GBLP
For 52 weeks
0.15 USD
0.35 USD
50 Day MA
0.26 USD
Shares Short Prior Month
–
200 Day MA
0.27 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart